Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
HCW Biologics Inc. (HCWB) had Return on Investments of -126.45% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$2.84M |
|
$-24.99M |
|
$2.28M |
|
$0.56M |
|
$28.56M |
|
$-25.72M |
|
$0.72M |
|
$-24.99M |
|
$-24.99M |
|
$-24.99M |
|
$-24.99M |
|
$-24.99M |
|
$-24.99M |
|
$-25.72M |
|
$-24.58M |
|
35.93M |
|
35.93M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$6.40M |
|
$20.45M |
|
$22.11M |
|
$28.51M |
|
$8.75M |
|
$6.30M |
|
$6.30M |
|
$15.05M |
|
$13.46M |
|
$13.46M |
|
$13.46M |
|
36.02M |
|
| Cash Flow Statement Financials | |
$-22.51M |
|
$3.80M |
|
$-0.01M |
|
$22.33M |
|
$3.60M |
|
$-18.73M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.73 |
|
-- |
|
-- |
|
0.32 |
|
0.47 |
|
19.72% |
|
-904.96% |
|
-904.96% |
|
-865.02% |
|
-879.52% |
|
-879.52% |
|
$-28.72M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
1.85 |
|
197.25 |
|
-185.67% |
|
-185.67% |
|
-87.66% |
|
|
Return on Investments |
-126.45% |
$0.37 |
|
$-0.80 |
|
$-0.63 |
|